Xtant Medical Holdings Statistics
Total Valuation
XTNT has a market cap or net worth of $76.02 million. The enterprise value is $98.11 million.
| Market Cap | 76.02M |
| Enterprise Value | 98.11M |
Important Dates
The next estimated earnings date is Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XTNT has 140.00 million shares outstanding. The number of shares has increased by 11.96% in one year.
| Current Share Class | 140.00M |
| Shares Outstanding | 140.00M |
| Shares Change (YoY) | +11.96% |
| Shares Change (QoQ) | +1.21% |
| Owned by Insiders (%) | 12.55% |
| Owned by Institutions (%) | 14.31% |
| Float | 54.04M |
Valuation Ratios
The trailing PE ratio is 48.57.
| PE Ratio | 48.57 |
| Forward PE | n/a |
| PS Ratio | 0.57 |
| Forward PS | 0.66 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | 14.70 |
| P/OCF Ratio | 9.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.00, with an EV/FCF ratio of 18.97.
| EV / Earnings | 56.03 |
| EV / Sales | 0.74 |
| EV / EBITDA | 9.00 |
| EV / EBIT | 15.46 |
| EV / FCF | 18.97 |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.64.
| Current Ratio | 2.21 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | 6.28 |
| Interest Coverage | 1.55 |
Financial Efficiency
Return on equity (ROE) is 3.64% and return on invested capital (ROIC) is 6.51%.
| Return on Equity (ROE) | 3.64% |
| Return on Assets (ROA) | 3.87% |
| Return on Invested Capital (ROIC) | 6.51% |
| Return on Capital Employed (ROCE) | 8.96% |
| Weighted Average Cost of Capital (WACC) | 5.22% |
| Revenue Per Employee | $573,634 |
| Profits Per Employee | $7,547 |
| Employee Count | 232 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 1.22 |
Taxes
In the past 12 months, XTNT has paid $508,000 in taxes.
| Income Tax | 508,000 |
| Effective Tax Rate | 22.49% |
Stock Price Statistics
The stock price has increased by +10.95% in the last 52 weeks. The beta is -0.18, so XTNT's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | +10.95% |
| 50-Day Moving Average | 0.60 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 37.02 |
| Average Volume (20 Days) | 143,398 |
Short Selling Information
The latest short interest is 23,175, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 23,175 |
| Short Previous Month | 28,112 |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 0.25 |
Income Statement
In the last 12 months, XTNT had revenue of $133.08 million and earned $1.75 million in profits. Earnings per share was $0.01.
| Revenue | 133.08M |
| Gross Profit | 82.54M |
| Operating Income | 6.35M |
| Pretax Income | 2.26M |
| Net Income | 1.75M |
| EBITDA | 10.90M |
| EBIT | 6.35M |
| Earnings Per Share (EPS) | $0.01 |
Balance Sheet
The company has $10.40 million in cash and $32.49 million in debt, with a net cash position of -$22.09 million or -$0.16 per share.
| Cash & Cash Equivalents | 10.40M |
| Total Debt | 32.49M |
| Net Cash | -22.09M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 50.38M |
| Book Value Per Share | 0.36 |
| Working Capital | 42.83M |
Cash Flow
In the last 12 months, operating cash flow was $7.83 million and capital expenditures -$2.66 million, giving a free cash flow of $5.17 million.
| Operating Cash Flow | 7.83M |
| Capital Expenditures | -2.66M |
| Depreciation & Amortization | 4.55M |
| Net Borrowing | -6.65M |
| Free Cash Flow | 5.17M |
| FCF Per Share | $0.04 |
Margins
Gross margin is 62.02%, with operating and profit margins of 4.77% and 1.32%.
| Gross Margin | 62.02% |
| Operating Margin | 4.77% |
| Pretax Margin | 1.70% |
| Profit Margin | 1.32% |
| EBITDA Margin | 8.19% |
| EBIT Margin | 4.77% |
| FCF Margin | 3.89% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.96% |
| Shareholder Yield | -11.96% |
| Earnings Yield | 2.30% |
| FCF Yield | 6.80% |
Analyst Forecast
The average price target for XTNT is $1.50, which is 176.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1.50 |
| Price Target Difference | 176.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 14, 2018. It was a reverse split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
XTNT has an Altman Z-Score of -0.6 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.6 |
| Piotroski F-Score | 8 |